Stockreport

Evaxion Announces Business Update and First Quarter 2023 Financial Results

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Full read-out of the Phase 1/2a trial of EVX-02 in 10 patients with completely resected melanoma was presented at AACR in April 2023, meeting primary endpoints and demon [Read more]